Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4586029

CCOC(=O)c1cnc2ccc(C=C3SC(Nc4c(Cl)cccc4Cl)=NC3=O)cc2c1-c1ccncc1.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.40
TP53 P04637 1/20 0.39
PDE5A O76074 1/20 0.39
CISD1 Q9NZ45 1/20 0.38
MAPT P10636 8/20 0.37
CREBBP Q92793 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
PKM P14618 1/20 0.37
THRB P10828 1/20 0.36
HTT P42858 1/20 0.36
CA2 P00918 1/20 0.36
GAA P10253 2/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
AURKA O14965 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2998139 1.00 SRC (0.40) SRCTP53PDE5ACISD1MAPT
Trifluoroacetic Acid SCHEMBL4587416 0.90 CLK1 (0.36) SRCTP53CISD1
SCHEMBL4586095 0.84 MAPT (0.44) SRCTP53CISD1MAPTCREBBP
SCHEMBL2984471 0.84 MAPT (0.44) SRCTP53CISD1MAPTCREBBP
SCHEMBL2993014 0.83 MAPT (0.45) SRCTP53CISD1MAPTCREBBP
SCHEMBL5049986 0.83 MAPT (0.45) SRCTP53CISD1MAPTCREBBP
Trifluoroacetic Acid SCHEMBL2998142 0.83 FABP3 (0.43) CISD1
SCHEMBL5049846 0.81 GAA (0.44) TP53CISD1MAPTCREBBPSMN1; SMN2
SCHEMBL2993653 0.81 GAA (0.44) TP53CISD1MAPTCREBBPSMN1; SMN2
Trifluoroacetic Acid SCHEMBL5054365 0.81 CISD1 (0.41) TP53CISD1MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214455-A1 Novel Chemical Compounds SMITHKLINE BEECHAM CORPORATION 2008-09-04 US disclosed
EP-1879563-A4 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2008-07-16 EP disclosed
EP-1879563-A2 NOVEL CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-01-23 EP disclosed
WO-2006132739-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214455-A1 Novel Chemical Compounds HIPK3, HIPK1, HIPK4 SRC 2902/4885TP53 2984/4885PDE5A 3187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.